Bribes Or Another Way to cut Medicare Cost.

Major drug companies are essentially bribing generic rivals to delay the release of cheaper drugs, costing consumers billions of dollars a year — and the number of these deals surged by more than 60 percent last year.

Drug companies bribed generics
Just don't make cheap drugs.

Major drug companies are essentially bribing generic rivals to delay the release of cheaper drugs, costing consumers billions of dollars a year — and the number of these deals surged by more than 60 percent last year.

FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers’ Access to Lower-Cost Generic DrugsDeals Are Costing Taxpayers, Consumers Billions of Dollars“ Collusive deals to keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices,” said FTC Chairman Jon Leibowitz. “The increasing number of these deals is a win-win proposition for the pharmaceutical industry, but a lose-lose for everyone else.In recent years, certain brand-name companies have paid generic challengers to settle their patent challenges and delay the introduction of lower-cost medicines. Continue reading “Bribes Or Another Way to cut Medicare Cost.”

Featuring Recent Posts WordPress Widget development by YD